Liven Pharmaceuticals Statistics

Total Valuation

PSX:LIVEN has a market cap or net worth of PKR 8.09 billion. The enterprise value is 8.10 billion.

Market Cap	8.09B
Enterprise Value	8.10B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

PSX:LIVEN has 93.04 million shares outstanding. The number of shares has increased by 149.85% in one year.

Current Share Class	n/a
Shares Outstanding	93.04M
Shares Change (YoY)	+149.85%
Shares Change (QoQ)	-47.78%
Owned by Insiders (%)	7.21%
Owned by Institutions (%)	4.46%
Float	85.98M

Valuation Ratios

The trailing PE ratio is 23.18.

PE Ratio	23.18
Forward PE	n/a
PS Ratio	24.85
PB Ratio	8.95
P/TBV Ratio	9.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	71.31
EV / Sales	76.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-397.40

Financial Position

The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.03.

Current Ratio	4.28
Quick Ratio	2.17
Debt / Equity	0.03
Debt / EBITDA	1.29
Debt / FCF	-1.25
Interest Coverage	1,189.61

Financial Efficiency

Return on equity (ROE) is 29.29% and return on invested capital (ROIC) is 0.45%.

Return on Equity (ROE)	29.29%
Return on Assets (ROA)	0.43%
Return on Invested Capital (ROIC)	0.45%
Return on Capital Employed (ROCE)	0.41%
Revenue Per Employee	35.35M
Profits Per Employee	37.88M
Employee Count	3
Asset Turnover	0.19
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +748.30% in the last 52 weeks. The beta is -0.18, so PSX:LIVEN's price volatility has been lower than the market average.

Beta (5Y)	-0.18
52-Week Price Change	+748.30%
50-Day Moving Average	111.95
200-Day Moving Average	65.71
Relative Strength Index (RSI)	34.85
Average Volume (20 Days)	10,717

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PSX:LIVEN had revenue of PKR 106.04 million and earned 113.64 million in profits. Earnings per share was 3.75.

Revenue	106.04M
Gross Profit	34.29M
Operating Income	3.75M
Pretax Income	123.04M
Net Income	113.64M
EBITDA	19.68M
EBIT	3.75M
Earnings Per Share (EPS)	3.75

Full Income Statement

Balance Sheet

The company has 14.81 million in cash and 25.46 million in debt, giving a net cash position of -10.65 million or -0.11 per share.

Cash & Cash Equivalents	14.81M
Total Debt	25.46M
Net Cash	-10.65M
Net Cash Per Share	-0.11
Equity (Book Value)	904.28M
Book Value Per Share	9.72
Working Capital	218.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -19.81 million and capital expenditures -585,300, giving a free cash flow of -20.39 million.

Operating Cash Flow	-19.81M
Capital Expenditures	-585,300
Free Cash Flow	-20.39M
FCF Per Share	-0.22

Full Cash Flow Statement

Margins

Gross margin is 32.34%, with operating and profit margins of 3.53% and 107.17%.

Gross Margin	32.34%
Operating Margin	3.53%
Pretax Margin	116.04%
Profit Margin	107.17%
EBITDA Margin	18.56%
EBIT Margin	3.53%
FCF Margin	n/a

Dividends & Yields

PSX:LIVEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-149.85%
Shareholder Yield	-149.85%
Earnings Yield	1.40%
FCF Yield	-0.25%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PSX:LIVEN has an Altman Z-Score of 3.89.

Altman Z-Score	3.89
Piotroski F-Score	n/a